Vancouver, October 28, 2016.
Insight Diagnostics Inc. has signed a Memorandum of Understanding (MOU) with BC Diabetes (BCDiabetes.ca, doing business as Dr. T. G. Elliot Inc.) to conduct a clinical test of Insight's mobile diabetes diagnostic device and to jointly develop improved diagnostic tools for diabetes management.
This MOU will set out the agreement between the parties necessary to undertake research and development activities for the identification, refinement and testing of mobile diagnostic platforms for diabetes patients.
Dean Sutton, CEO of Insight Diagnostics commented: "A well researched, controlled and executed clinical trial is a great forward moving step for Insight. We couldn't be happier to be working with BC Diabetes and Dr. Tom Elliott on this, there's simply no better physician or clinic to undertake such a trial."
This MOU is effective from the date of signing and will remain in effect until modified by the parties involved.
BCDiabetes.ca is a Vancouver based diabetes clinic that has a specialty in clinical management of diabetes, with access to 5,000 diabetic patients electronic records, and has expertise in conducting clinical research. Learn more at www.BCdiabetes.ca
Insight Diagnostics is an award winning Vancouver-based startup with technical expertise in mobile point-of-care (POC) diagnostics. Their specialty lies in microfluidics, electrochemical detection, materials chemistry and secure wireless communication.
For more information please contact;
Dean Sutton, CEO, Insight Diagnostics Inc.